Fortress Biotech is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceutical and biotechnology products and product candidates. Through its partner company, Co. markets the following dermatology products: Ximino®, which is a tetracycline-class drug indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox®, which is a tetracycline-class drug indicated as adjunctive therapy for severe acne; and Ceracade®, which is a steroid-free, ceramide-dominant formulation used to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatitis and radiation dermatitis.

Preferred: FBIOP